The putative tumor suppressor microRNA-30a-5p modulates clear cell renal cell carcinoma aggressiveness through repression of ZEB2

Clear cell renal cell carcinoma (ccRCC), the most common subtype of renal cell carcinoma, can easily invade local tissues and metastasize, and is resistant to currently available treatments. Recent studies profiling microRNA expression in ccRCC have suggested miR-30a-5p may be deregulated in these cancer cells. To determine its role and mechanism of action in ccRCC, miR-30-5p expression levels were quantified and functions were analyzed using in vitro and in vivo experiments and bioinformatics. A decrease in miR-30a-5p expression was frequently noted in ccRCC cells and tissues. Importantly, low miR-30a-5p levels were significantly associated with a poor ccRCC patient prognosis. Stable overexpression of miR-30a-5p in 769-P cells was sufficient to prevent cellular proliferation and invasion in vitro and in vivo. Upon further examination, it was found that miR-30a-5p directly targeted the 3′-UTR of ZEB2 and suppressed ccRCC cell epithelial–mesenchymal transition. In addition, miR-30a-5p may be downregulated by the long non-coding RNA DLEU2. Taken together, these data reveal an important role for miR-30a-5p in the regulation of ccRCC proliferation and invasion, and indicate the potential for miR-30a-5p in applications furthering ccRCC prognostics and therapeutics.

[1]  J. Foidart,et al.  Regulation of vimentin by SIP1 in human epithelial breast tumor cells , 2006, Oncogene.

[2]  G. Hannon,et al.  Control of translation and mRNA degradation by miRNAs and siRNAs. , 2006, Genes & development.

[3]  J. Nesland,et al.  Snail, Slug, and Smad‐interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma , 2005, Cancer.

[4]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[5]  K. Birkenkamp-Demtroder,et al.  MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL. , 2012, Carcinogenesis.

[6]  A. Evans,et al.  miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215 , 2011, British Journal of Cancer.

[7]  V. Bilim,et al.  Re-expression of miR-199a suppresses renal cancer cell proliferation and survival by targeting GSK-3β. , 2012, Cancer letters.

[8]  Paul L. Roebuck,et al.  TANRIC: An Interactive Open Platform to Explore the Function of lncRNAs in Cancer. , 2015, Cancer research.

[9]  W Marston Linehan,et al.  Genetic basis of kidney cancer: Role of genomics for the development of disease-based therapeutics , 2012, Genome research.

[10]  Yumei Du,et al.  Elevation of Highly Up-regulated in Liver Cancer (HULC) by Hepatitis B Virus X Protein Promotes Hepatoma Cell Proliferation via Down-regulating p18* , 2012, The Journal of Biological Chemistry.

[11]  G. Yousef,et al.  miRNA-target network reveals miR-124as a key miRNA contributing to clear cell renal cell carcinoma aggressive behaviour by targeting CAV1 and FLOT1 , 2015, Oncotarget.

[12]  G. Berx,et al.  The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. , 2001, Molecular cell.

[13]  M. Stern,et al.  MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor , 2013, Oncogene.

[14]  D. Rimm,et al.  X-Tile , 2004, Clinical Cancer Research.

[15]  Hui Zhou,et al.  starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data , 2013, Nucleic Acids Res..

[16]  Hanlin Gao,et al.  MicroRNA profiling of clear cell renal cell carcinoma by whole‐genome small RNA deep sequencing of paired frozen and formalin‐fixed, paraffin‐embedded tissue specimens , 2010, The Journal of pathology.

[17]  Doron Betel,et al.  The microRNA.org resource: targets and expression , 2007, Nucleic Acids Res..

[18]  J. Massagué,et al.  Epithelial-Mesenchymal Transitions Twist in Development and Metastasis , 2004, Cell.

[19]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[20]  G. Bhanot,et al.  Identification of a microRNA panel for clear-cell kidney cancer. , 2010, Urology.

[21]  J. Thiery Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[22]  N. Seki,et al.  Epithelial–mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma , 2013, Journal of Human Genetics.

[23]  K. Imai,et al.  Expression of SIP1 in oral squamous cell carcinomas: implications for E-cadherin expression and tumor progression. , 2005, International journal of oncology.

[24]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[25]  Andrea Califano,et al.  The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. , 2010, Cancer cell.

[26]  Jun‐hang Luo,et al.  Protein Expression of ZEB2 in Renal Cell Carcinoma and Its Prognostic Significance in Patient Survival , 2013, PloS one.

[27]  槻木 真明 Re-expression of miR-199a suppresses renal cancer cell proliferation and survival by targeting GSK-3β , 2012 .

[28]  K. Miyazaki,et al.  Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells , 2004, British Journal of Cancer.

[29]  Wenfang Li,et al.  Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway , 2016, Tumor Biology.

[30]  Andrea Ventura,et al.  MicroRNAs and Cancer: Short RNAs Go a Long Way , 2009, Cell.

[31]  R. Plasterk,et al.  The diverse functions of microRNAs in animal development and disease. , 2006, Developmental cell.

[32]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.

[33]  Xing-Sui Lu,et al.  miR-141 Is a Key Regulator of Renal Cell Carcinoma Proliferation and Metastasis by Controlling EphA2 Expression , 2014, Clinical Cancer Research.

[34]  Birgit Luber,et al.  Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. , 2002, The American journal of pathology.

[35]  Chaochun Liu,et al.  The imprinted H19 lncRNA antagonizes let-7 microRNAs. , 2013, Molecular cell.

[36]  Lin He,et al.  MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature Reviews Genetics.

[37]  R. Dahiya,et al.  MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer. , 2011, Cancer research.

[38]  Rajvir Dahiya,et al.  MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells. , 2011, Cancer research.

[39]  M. Seto,et al.  Genome‐wide microRNA expression profiling in renal cell carcinoma: significant down‐regulation of miR‐141 and miR‐200c , 2008, The Journal of pathology.

[40]  Yi-Hsuan Chen,et al.  miRNAMap 2.0: genomic maps of microRNAs in metazoan genomes , 2007, Nucleic Acids Res..

[41]  Jarek Meller,et al.  VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma. , 2012, Cancer cell.

[42]  Ke Chen,et al.  LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma , 2015, Oncotarget.

[43]  H. Dweep,et al.  miRWalk2.0: a comprehensive atlas of microRNA-target interactions , 2015, Nature Methods.

[44]  D. Cacchiarelli,et al.  A Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNA , 2011, Cell.

[45]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Masaomi Kato,et al.  microRNAs: small molecules with big roles –C. elegans to human cancer , 2008, Biology of the cell.

[47]  H. Al-Ahmadie,et al.  Recent developments in the pathology of renal tumors: morphology and molecular characteristics of select entities. , 2009, Archives of pathology & laboratory medicine.